ImmunoCellular Therapeutics announces agreement on terms of settlement
ImmunoCellular Therapeutics announced it has reached an agreement in principle to settle the securities class action suit, filed on May 1, 2017 in the U.S. District Court against the Company, certain of its current and former officers and directors, and others.
July 19, 2018